ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,025.99
-0.95%
US Tech 100
20,874.00
-1.46%
다우존스 지수
44,303.40
-0.99%
Bitcoin
96,664.06
0.21%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Repligen Corp (RGEN) 시세

Repligen Corp

Repligen Corp (RGEN)

NASDAQ
156.05
-5.81
(-3.59%)
마감 09 2월 6:00AM
15분 지연
156.05
-0.13
(-0.08%)
시간외 거래: 7:33AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
156.05
매수가
133.11
매도가
163.69
거래량
401,223
154.68 일간 변동폭 161.395
113.50 52주 범위 211.13
market_cap
8.743B
전일 종가
161.86
개장가
160.445
최근 거래 시간
2
@
155
마지막 거래 시간
재정 규모
US$ 62,998,386
VWAP
157.0159
평균 볼륨(3m)
568,949
발행 주식
56,026,725
배당수익률
-
주가수익률
245.84
주당순이익(EPS)
0.64
매출
662.93M
순이익
35.6M

Repligen Corp 정보

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceuti... Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.repligen.com
본부
Wilmington, Delaware, USA
설립됨
-
Repligen Corp is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker RGEN. The last closing price for Repligen was US$161.86. Over the last year, Repligen shares have traded in a share price range of US$ 113.50 to US$ 211.13.

Repligen currently has 56,026,725 shares in issue. The market capitalisation of Repligen is US$9.07 billion. Repligen has a price to earnings ratio (PE ratio) of 245.84.

RGEN 최신 뉴스

추가 뉴스

Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will...

07 1월 2025
GlobeNewswire Inc.

Repligen Launches the CTech™ SoloVPE® PLUS System

WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial...

06 1월 2025
GlobeNewswire Inc.

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors PR Newswire BOTHELL, Wash., Dec. 16, 2024 BOTHELL, Wash., Dec. 16, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq:...

16 12월 2024
PR Newswire (US)

Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report

WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital...

12 12월 2024
GlobeNewswire Inc.

Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns

WALTHAM, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of...

09 12월 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

06 12월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

23 11월 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

22 11월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

22 11월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

22 11월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-11.52-6.87473891508167.57170.435156.05431305161.6984109CS
43.2752.14367533955152.775181.66150.23603810164.07382827CS
1217.32512.4887367093138.725181.66121.52568949151.11516102CS
26-7.95-4.84756097561164181.66121.52640669147.93107738CS
52-45.28-22.4904385834201.33211.13113.5640875152.55046074CS
156-44.38-22.1423938532200.43262.26110.45594721165.59244027CS
26055.7355.5522328549100.32327.3278.41535682169.85926653CS

RGEN - Frequently Asked Questions (FAQ)

What is the current Repligen share price?
The current share price of Repligen is US$ 156.05
How many Repligen shares are in issue?
Repligen has 56,026,725 shares in issue
What is the market cap of Repligen?
The market capitalisation of Repligen is USD 9.07B
What is the 1 year trading range for Repligen share price?
Repligen has traded in the range of US$ 113.50 to US$ 211.13 during the past year
What is the PE ratio of Repligen?
The price to earnings ratio of Repligen is 245.84
What is the cash to sales ratio of Repligen?
The cash to sales ratio of Repligen is 13.2
What is the reporting currency for Repligen?
Repligen reports financial results in USD
What is the latest annual turnover for Repligen?
The latest annual turnover of Repligen is USD 662.93M
What is the latest annual profit for Repligen?
The latest annual profit of Repligen is USD 35.6M
What is the registered address of Repligen?
The registered address for Repligen is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Repligen website address?
The website address for Repligen is www.repligen.com
Which industry sector does Repligen operate in?
Repligen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
816.59M
CDTConduit Pharmaceuticals Inc
US$ 2.831
(82.65%)
144.17M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
219.64M
TOIIWOncology Institute Inc
US$ 0.033
(58.88%)
7.27k
CYTHCyclo Therapeutics Inc
US$ 1.19
(54.55%)
84.73M
FTELFitell Corporation
US$ 2.70
(-57.01%)
2.28M
SGBXSafe and Green Holdings Corporation
US$ 0.6401
(-44.82%)
5.15M
NKLANikola Corporation
US$ 0.4432
(-41.10%)
47.43M
PLRXPliant Therapeutics Inc
US$ 7.785
(-34.85%)
6.4M
LIPOLipella Pharmaceuticals Inc
US$ 3.08
(-33.76%)
2.08M
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
816.59M
RIMEAlgorhythm Holdings Inc
US$ 0.0169
(-20.66%)
274.2M
NVDANVIDIA Corporation
US$ 129.84
(0.90%)
228.2M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
219.64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0537
(14.74%)
212.29M

RGEN Discussion

게시물 보기
Monksdream Monksdream 3 월 전
RGEN under $200
👍️0
Monksdream Monksdream 5 월 전
RGEN under $200
👍️0
Monksdream Monksdream 6 월 전
RGEN under $200
👍️0
Monksdream Monksdream 10 월 전
RGEN over $30
👍️0
Monksdream Monksdream 12 월 전
RGEN new 52 week high
👍️0
Dennisb68 Dennisb68 1 년 전
Hoping it holds.
👍️0
Monksdream Monksdream 1 년 전
RGEN new 52 week high
👍️0
Dennisb68 Dennisb68 1 년 전
Another very good day for RGEN. Up 6.8%
👍️0
Dennisb68 Dennisb68 2 년 전
Good day for RGEN. Hope we see more of them.
👍️0
Dennisb68 Dennisb68 2 년 전
Do these execs ever BUY the stock?
👍️0
Dennisb68 Dennisb68 3 년 전
It had great earning last quarter.
👍️0
Dennisb68 Dennisb68 3 년 전
Good day. Over $300 at one point.
👍️0
Dennisb68 Dennisb68 3 년 전
She continues to make new highs almost daily.
👍️0
Dennisb68 Dennisb68 3 년 전
Another new closing high. It just gets better and better.
👍️0
Dennisb68 Dennisb68 3 년 전
New high, $300.00 in AH trading.
👍️0
Dennisb68 Dennisb68 3 년 전
Still making new highs almost daily.
👍️0
Dennisb68 Dennisb68 3 년 전
It continues to make new highs...
👍️0
Dennisb68 Dennisb68 4 년 전
Today was the biggest gain ever for RGEN.
👍️0
Dennisb68 Dennisb68 4 년 전
WOW, What a quarter!
https://finance.yahoo.com/news/repligen-reports-second-quarter-2021-113000794.html
👍️0
Dennisb68 Dennisb68 4 년 전
Lost a little ground today. Back below $205.
👍️0
Dennisb68 Dennisb68 4 년 전
Still holding above $205 and after the recent run I'm happy with that.
👍️0
Dennisb68 Dennisb68 4 년 전
Good to see the stock above $205 again.
👍️0
Dennisb68 Dennisb68 4 년 전
HC Wainwright & Co. boosted the price target for Repligen Corporation
RGEN 0.53%
from $168 to $225.
👍️0
Dennisb68 Dennisb68 4 년 전
RGEN hit a new all time high today.
👍️0
Dennisb68 Dennisb68 4 년 전
Actually it a little more than doubled in 2020. It closed 2019 at 92.50 and it closed 2020 at 191.63 for a 107% gain. If it doubles again in 2021 I will be paying a LOT of taxes.
👍️0
Jamins Jamins 4 년 전
222.06 today. Doubled in value in 2020 and company says it will do it again in 2021. So what do you got to lose?
👍️0
Dennisb68 Dennisb68 4 년 전
RGEN having a great day but not seeing any news to justify it. Perhaps news of an acquisition is coming?
👍️0
Dennisb68 Dennisb68 4 년 전
I sold half my shares at $159 and was able to get back in at $143. If we get a nice run higher I my sell again and wait for a dip to get back in. Just watching it day by day.
👍️0
keepemcloser keepemcloser 4 년 전
Same here,we feel comfortable at this level.
👍️0
Dennisb68 Dennisb68 4 년 전
Great earnings and the stock closes at another all time high.
👍️0
Dennisb68 Dennisb68 4 년 전
Stock closed at another all time closing high.
👍️0
Dennisb68 Dennisb68 4 년 전
Moved higher in AH trading.
👍️0
Dennisb68 Dennisb68 4 년 전
The stock continues to make new highs. $170 and headed for $200.
👍️0
Dennisb68 Dennisb68 4 년 전
RGEN hit a new 52 week high today.
👍️0
Dennisb68 Dennisb68 5 년 전
Thank you. Yes a very nice profit as I bought these at about $3.50 a share. I'm still holding quite a few shares.
👍️0
Hitman970 Hitman970 5 년 전
Nice profit! I am new here and long!
👍️0
Dennisb68 Dennisb68 5 년 전
Sold half my position this morning. Like the stock but feel the markets are due for a dip.
👍️0
Dennisb68 Dennisb68 5 년 전
Up another $2 in AH trading. Hope it holds. I think we could see $165 in the near future. What I would love to see the company do is a stock split about 1 for 5 or 1 for 8. I have talked to the company and they have said they have given it some thought but nothing yet.
👍️0
Hitman970 Hitman970 5 년 전
Holding for the big move
👍️0
Dennisb68 Dennisb68 5 년 전
Are you still holding your share after today's run?
👍️0
Dennisb68 Dennisb68 5 년 전
Earnings:

https://www.otcmarkets.com/filing/html?id=14296416&guid=d5eFUHutqUUibth
👍️0
Dennisb68 Dennisb68 5 년 전
Earning out and they are GREAT..

👍️0
Dennisb68 Dennisb68 5 년 전
Another very nice day. Currently trading over $140,00
👍️0
Dennisb68 Dennisb68 5 년 전
$139.00 in Pre Mkt. this morning.
👍️0
Dennisb68 Dennisb68 5 년 전
The majority of the stocks I trade are OTC stocks.
👍️0
Hitman970 Hitman970 5 년 전
TDA and E*TRADE charge no fees on non otcs
👍️0
Dennisb68 Dennisb68 5 년 전
Really? Check your statement to see if you aren't paying any fees.
👍️0
Hitman970 Hitman970 5 년 전
BTW no brokers charge commission fees anymore.
👍️0
Hitman970 Hitman970 5 년 전
Yes of course. I’m not wealthy and am 37. Just began investing in this after lengthy due diligence led me here.
👍️0
Dennisb68 Dennisb68 5 년 전
When I buy stocks I pay a $7 commission if I buy 1 share or 100 shares. If I bought 1 share for $130 it would cost me $137 with commission. And then when I sold it I would have to pay another $7 in commission so I would have to sell that stock I bought for $130 for $144 just to break even.
👍️0

최근 히스토리

NASDAQ
RGEN
Repligen
BIT
1LOW
Lowes Cos
BIT
HER
Hera
COIN
MTVGBP
MultiVAC
BIT
UC838Y
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지